Helicobacter pylori infection and non-alcoholic fatty liver disease in the working population of South Yakutia: association research
https://doi.org/10.25789/YMJ.2023.83.27
Abstract
A one-time study of the working population of non-indigenous nationality in the southern zone of Yakutia was carried out. A total of 78 people were analyzed, including 31 men, Me age 45.0 [35.0-54.0] years, and 47 women, Me - 43.5 [36.0-53.0] years. A high incidence of Helicobacter pylori infection was found, regardless of comorbidity. The association of HP infection with body mass index, waist circumference, lipid spectrum disorders and metabolic syndrome according to IDF 2005 criteria was not obtained (p˃0.05). In the course of the study, the relationship between NAFLD and infection with Helicobacter pylori infection was not obtained (p˃0.05).
About the Authors
S. I. Sofronova
Yakut Science Centre of Complex Medical Problems (YSC CMP)
Russian Federation
Russian Federation
SOFRONOVA Sargylana Ivanovna – PhD, chief researcher, head of the Department
Yakutsk
V. M. Nikolaev
Yakut Science Centre of Complex Medical Problems (YSC CMP)
Russian Federation
Russian Federation
NIKOLAEV Vyacheslav Mikhailovich – PhD in Biology, chief researcher
Yakutsk
M. P. Kirillina
Yakut Science Centre of Complex Medical Problems (YSC CMP)
Russian Federation
Russian Federation
KIRILLINA Maria Petrovna –PhD in Biology, visiting scholar
Yakutsk
A. N. Romanova
Yakut Science Centre of Complex Medical Problems (YSC CMP)
Russian Federation
Russian Federation
ROMANOVA Anna Nikolaevna – MD, Director of the YSC CMP
Yakutsk
E. D. Okhlopkova
Yakut Science Centre of Complex Medical Problems (YSC CMP)
Russian Federation
Russian Federation
OKHLOPKOVA Elena Dmitrievna – PhD in Biology, senior researcher
Yakutsk
References
1. Clinical guidelines for the diagnosis and treatment of non-alcoholic fatty liver disease of the Russian Society for the Study of the Liver and the Russian Gastroenterological Association / IvashkinV.T., MayevskayaM.V., PavlovCh.S., et al.. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2016;26(2):24-42. DOI:10.22416/1382-4376-2016-26-2-24-42
2. Non-alcoholic fatty liver disease in the patients presenting with abdominal obesity / Livzan MA, et al. Russian Journal of Evidence-Based Gastroenterology. 2014;3(4):8 14. https://doi.org/10.17116/dokgastro2014348-14
3. Sofronova S.I., Romanova A.N. Characteristics of pathological involvement of the working population of the southern zone of Yakutia // Yakut medical journal. 2022. No. 4. P. 52-55. DOI: 10.25789/YMJ.2022.80.14
4. Chelakkot C, Ghim J, Ryu S. Mechanisms regulating intestinal barrier integrity and its pathological implications // Exp Mol Med. 2018; 50:1–9. https://doi.org/10.1038/s12276-018-0126-x
5. Chen X, Shi F, Xiao J, et al. Associations Between Abdominal Obesity Indices and Nonalcoholic Fatty Liver Disease: Chinese Visceral Adiposity Index // Front Endocrinol (Lausanne). 2022; 13: 831960. doi: 10.3389/fendo.2022.831960.
6. European Association for the Study of the Liver (EASL). European Association for the Study of Diabetes (EASD). European Association for the Study of Obesity (EASO). EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease // J. Hepatol. 2016; 64 (6):1388-1402.
7. Fan N, Peng L, Xia Zh, et al. Helicobacter pylori Infection Is Not Associated with Non-alcoholic Fatty Liver Disease: A Cross-Sectional Study in China // Front Microbiol. 2018 Jan 31;9:73. doi: 10.3389/fmicb.2018.00073
8. Heydari K, Yousefi M, Alizadeh-Navaei R, et al. Helicobacter pylori Infection and Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis // Turk J Gastroenterol. 2022 Mar;33(3):171-181. DOI: 10.5152/tjg.2022.21467
9. Jichitu A, Bungau S, Stanescu A, et al. Non-alcoholic fatty liver disease and cardiovascular comorbidities: pathophysiological links, diagnosis, and therapeutic management. diagnostics (Basel). 2021;11(4):689. DOI:10.3390/diagnostics11040689
10. Kapil S, Duseja A, Sharma B, et al. Small intestinal bacterial overgrowth and toll-like receptor signaling in patients with non-alcoholic fatty liver disease // J. Gastroenterol. Hepatol. 2016; 31: 213-221. DOI: 10.1111/jgh.13058
11. Kim TJ, Sinn DH, Min YW, et al. A cohort study on Helicobacter pylori infection associated with nonalcoholic fatty liver disease // J Gastroenterol. 2017 Nov;52(11):1201-1210. doi: 10.1007/s00535-017-1337-y.
12. Mohammadifard M, Saremi Z, Rastgoo M, Akbari E. Relevance between Helicobacter pylori Infection and Non-Alcoholic Fatty Liver Disease in Birjand, Iran // J Med Life. 2019 Apr-Jun;12(2):168-172. DOI: 10.25122/jml-2019-0012
13. Nier A, Engstler A, Maier I, Bergheim I. Markers of intestinal permeability are already altered in early stages of nonalcoholic fatty liver disease: Studies in children. PLoS One. 2017 Sep 7; 12(9): e0183282. DOI: 10.1371/journal.pone.0183282
14. Wang W, Fan M, Gong R, et al. Helicobacter pylori infection is not an independent risk factor of non-alcoholic fatty liver disease in China // BMC Gastroenterol. 2022 Feb 24;22(1):81. DOI: 10.1186/s12876-022-02148-6
15. Wernly S, Wernly B, Semmler G, et al. Non-alcoholic fatty liver disease is not independently associated with Helicobacter pylori in a central European screening cohort // Minerva Med. 2022 Dec;113(6):936-949. doi: 10.23736/S0026-4806.22.07928-9
16. Xu G, Ma Sh, Dong L, et al. Relationship of Helicobacter pylori Infection with Nonalcoholic Fatty Liver Disease: A Meta-Analysis // Can J Gastroenterol Hepatol. 2023 Jan 25;2023:5521239. DOI: 10.1155/2023/5521239
Review
For citations:
Sofronova S.I., Nikolaev V.M., Kirillina M.P., Romanova A.N., Okhlopkova E.D. Helicobacter pylori infection and non-alcoholic fatty liver disease in the working population of South Yakutia: association research. Yakut Medical Journal. 2023;(3):111-114. https://doi.org/10.25789/YMJ.2023.83.27
Views:
21
Email this article 